Weill Cornell Medicine professor Christopher Mason has swabbed the NYC subway system before with surprising results. Now, with help from Twist Bioscience’s NGS Target Enrichment tools for Coronavirus, Chris is sampling the public transit system to see if and where the novel coronavirus is residing. Chris will be in conversation with Twist CEO Emily Leproust, as well as Josh Perfetto, founder and CEO of Chai Bio, which makes tools like Open qPCR accessible to researchers everywhere. We will discuss how public swabbing works, and Josh will share results coming out in pre-print in the coming days.March 27, 2020, 8:00 AM Pacific Time